Family history of cancer and DNA damage response genes: Two sides of the same coin?

被引：1

作者：

Cortellini, Alessio ^{[1
,2
]}

Bersanelli, Melissa ^{[3
]}

Ficorella, Corrado ^{[1
,2
]}

Buti, Sebastiano ^{[3
]}

机构：

[1] St Salvatore Hosp, Dept Med Oncol, Laquila, Italy

[2] Univ Laquila, Dept Biotechnol & Appl Clin Sci, Laquila, Italy

[3] Univ Hosp Parma, Dept Med Oncol, Parma, Italy

来源：

THORACIC CANCER | 2019年 / 10卷 / 02期

关键词：

D O I：

10.1111/1759-7714.12926

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：401 / 401

页数：1

共 4 条

[1] Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study [J].

Cortellini, Alessio ;

Bersanelli, Melissa ;

Buti, Sebastiano ;

Gambale, Elisabetta ;

Atzori, Francesco ;

Zoratto, Federica ;

Parisi, Alessandro ;

Brocco, Davide ;

Pireddu, Annagrazia ;

Cannita, Katia ;

Iacono, Daniela ;

Migliorino, Maria R. ;

Gamucci, Teresa ;

De Tursi, Michele ;

Sidoni, Tina ;

Tiseo, Marcello ;

Michiara, Maria ;

Papa, Anselmo ;

Angius, Gesuino ;

Tomao, Silverio ;

Fargnoli, Maria C. ;

Natoli, Clara ;

Ficorella, Corrado .

IMMUNOTHERAPY, 2018, 10 (08) :643-655

[2] Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond [J].

Hall, M. J. ;

Obeid, E. I. ;

Schwartz, S. C. ;

Mantia-Smaldone, G. ;

Forman, A. D. ;

Daly, M. B. .

GYNECOLOGIC ONCOLOGY, 2016, 140 (03) :565-574

[3] Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers [J].

Teo, Min Yuen ;

Seier, Kenneth ;

Ostrovnaya, Irina ;

Regazzi, Ashley M. ;

Kania, Brooke E. ;

Moran, Meredith M. ;

Cipolla, Catharine K. ;

Bluth, Mark J. ;

Chaim, Joshua ;

Al-Ahmadie, Hikmat ;

Snyder, Alexandra ;

Carlo, Maria I. ;

Solit, David B. ;

Berger, Michael F. ;

Funt, Samuel ;

Wolchok, Jedd D. ;

Iyer, Gopa ;

Bajorin, Dean F. ;

Callahan, Margaret K. ;

Rosenberg, Jonathan E. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1685-+

[4] DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer [J].

Zhu, Zhongling ;

Chen, Peng ;

Yan, Zhao .

THORACIC CANCER, 2018, 9 (08) :901-903

← 1 →